BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will make a presentation at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 10:30 a.m. ET. The conference is being held at The New York Palace hotel in New York City.
